Nursing Home & Elder Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Nursing Home & Elder Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acute Myeloid Leukemia
Study results from T. Prebet et al provide new insights into acute myeloid leukemia
November 15th, 2009
According to recent research from Marseille, France, "Acute myeloid leukemia (AML) with translocation (t) (8;21) or inversion (inv) (16) is associated with a favorable prognosis when treated with intensive chemotherapy. In elderly patients, these AML types are rare, and intensive treatments are much less tolerated." "We conducted a retrospective study to evaluate the characteristics and outcome of AML with t(8;21) or inv(16) in the elderly. Patients with t(8;21) or inv(16) AML who were age 60 years or older and who received at least one course of induction chemotherapy were included. Postremission therapy consisted of low-dose maintenance chemotherapy (n = 72) or...
Source: Nursing Home & Elder Business Week (2009-11-15)
|
